SCHEMBL9759423

SCHEMBL9759423

CCCN(CCC)C1CCc2cccc(CCNC(=O)OCC)c2C1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.55
HTR7 P34969 3/20 0.55
DRD2 P14416 2/20 0.55
HTR1D P28221 2/20 0.55
DRD3 P35462 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
TSHR P16473 1/20 0.55
HTR1B P28222 1/20 0.55
HTR2A P28223 1/20 0.55
HTR2C P28335 1/20 0.55
ADRA1A P35348 1/20 0.55
ADRA1B P35368 1/20 0.55
HTR2B P41595 1/20 0.55
HTR5A P47898 1/20 0.55
BLM P54132 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9759040 0.90 HTR1A (0.57) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9759427 0.90 HTR1A (0.50) HTR1AHTR7DRD2HTR1DDRD3
Hydrochloric Acid SCHEMBL9760000 0.89 HTR1A (0.56) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9758950 0.87 HTR1A (0.58) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9758050 0.86 HTR1A (0.57) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9759895 0.84 HTR1D (0.67) HTR1ADRD2HTR1DDRD3HTR1B
SCHEMBL9758475 0.80 HTR1A (0.57) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL10639628 0.79 HTR1A (0.56) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL9758412 0.79 HTR1A (0.61) HTR1AHTR7DRD2HTR1DDRD3
Hydrochloric Acid SCHEMBL9758088 0.78 HTR1A (0.55) HTR1AHTR7DRD2HTR1DDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047422-A Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract BAYER AKTIENGESELLSCHAFT (DE) 1991-09-10 US disclosed
US-4968679-A DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
US-4873262-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed
EP-0272534-A2 8-substituted 2-aminotetralins BAYER AG (DE) 1988-06-29 EP disclosed